Inventor · disambiguated record
Michael Palladino
Also filed as: PALLADINO JR MICHAEL A · PALLADINO MICHAEL · PALLADINO MICHAEL A · PALLADINO MICHAEL A JR
30 granted patents·14 pending applications·1,687 citations·filing 1985–2022
98Inventor score
Files withNEREUS PHARMACEUTICALS INC15GENENTECH INC6PALLADINO MICHAEL5UNIV CALIFORNIA4CELGENE INT II SARL3
Top patents by PatentIndex Score
44 records- 0198US7919497B2Analogs of dehydrophenylahistins and their therapeutic useNEREUS PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·78 cites·6 claims
- 0297US7674903B2Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofNEREUS PHARMACEUTICALS INC·Filed 2006·Granted Mar 9, 2010·35 cites·21 claims
- 0396US5795967ATumor necrosis factor antagonists and their useGENENTECH INC·Filed 1995·Granted Aug 18, 1998·350 cites·15 claims
- 0496US5672347ATumor necrosis factor antagonists and their useGENENTECH INC·Filed 1995·Granted Sep 30, 1997·280 cites·7 claims
- 0595US7026322B2Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compoundsNEREUS PHARMACEUTICALS INC·Filed 2003·Granted Apr 11, 2006·76 cites·10 claims
- 0694US8247552B2Analogs of dehydrophenylahistins and their therapeutic usePALLADINO MICHAEL·Filed 2011·Granted Aug 21, 2012·15 cites·12 claims
- 0794US7956058B2Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofNEREUS PHARMACEUTICALS INC·Filed 2006·Granted Jun 7, 2011·29 cites·39 claims
- 0894US7579371B2Methods of using [3.2.0] heterocyclic compounds and analogs thereofNEREUS PHARMACEUTICALS INC·Filed 2006·Granted Aug 25, 2009·27 cites·31 claims
- 0994US7572606B1Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogsNEREUS PHARMACEUTICALS INC·Filed 2006·Granted Aug 11, 2009·36 cites·18 claims
- 1094US5780426AFivemer cyclic peptide inhibitors of diseases involving αv β3IXSYS INC·Filed 1995·Granted Jul 14, 1998·137 cites·9 claims
- 1193US7935704B2Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofNEREUS PHARMACEUTICALS INC·Filed 2005·Granted May 3, 2011·20 cites·7 claims
- 1293US7064201B2Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofNEREUS PHARMACEUTICALS INC·Filed 2003·Granted Jun 20, 2006·50 cites·9 claims
- 1391US8129527B2Analogs of dehydrophenylahistins and their therapeutic usePALLADINO MICHAEL A·Filed 2007·Granted Mar 6, 2012·15 cites·1 claims
- 1491US5767071ASevenmer cyclic peptide inhibitors of diseases involving αv β3IXSYS INC·Filed 1995·Granted Jun 16, 1998·101 cites·10 claims
- 1591US5082658AGamma interferon-interleukin-2 synergismGENENTECH INC·Filed 1990·Granted Jan 21, 1992·112 cites·4 claims
- 1688US8618292B2Analogs of dehydrophenylahistins and their therapeutic usePALLADINO MICHAEL·Filed 2012·Granted Dec 31, 2013·12 cites·13 claims
- 1786US5135915AMethod for the treatment of grafts prior to transplantation using TGF-.beta.GENENTECH INC·Filed 1988·Granted Aug 4, 1992·160 cites·53 claims
- 1886US5055447AMethod and compositions for the treatment and prevention of septic shockGENENTECH INC·Filed 1989·Granted Oct 8, 1991·83 cites·9 claims
- 1984US7342125B2Method of treating inflammation with acanthoic acid derivativesNEREUS PHARMACEUTICALS INC·Filed 2005·Granted Mar 11, 2008·6 cites·12 claims
- 2084US6365768B1Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulatorsNEREUS PHARMACEUTICALS INC·Filed 2000·Granted Apr 2, 2002·18 cites·85 claims
- 2183US8168803B2Methods of using [3.2.0] heterocyclic compounds and analogs thereofPALLADINO MICHAEL·Filed 2008·Granted May 1, 2012·6 cites·12 claims
- 2282US8722724B2Compositions and methods for treating neoplastic diseasesANDERSON KENNETH C·Filed 2008·Granted May 13, 2014·4 cites·9 claims
- 2379US8394816B2Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's MacroglobulinemiaGHOBRIAL IRENE·Filed 2008·Granted Mar 12, 2013·5 cites·38 claims
- 2478US6881857B2Tricyclic diterpene derivativesUNIV CALIFORNIA·Filed 2002·Granted Apr 19, 2005·9 cites·17 claims
- 2578US2023210817A1Compositions and methods for treating neoplastic diseasesCELGENE INT II SARL·Filed 2022·Application pending·0 cites
- 2670US10610517B2Compositions and methods for treating neoplastic diseasesCELGENE INT II SARL·Filed 2014·Granted Apr 7, 2020·0 cites·4 claims
- 2767US2020206190A1Compositions and methods for treating neoplastic diseasesCELGENE INT II SARL·Filed 2020·Application pending·0 cites
- 2866US4714674AChemotactic assay for immunogenicityGENENTECH INC·Filed 1985·Granted Dec 22, 1987·23 cites·25 claims
- 2965US2008188475A1Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said ModulatorsNEREUS PHAMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3065US2008103328A1Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said ModulatorsNEREUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3161US2008280968A1Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseasesNEREUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3259US7119223B2Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulatorsUNIV CALIFORNIA·Filed 2002·Granted Oct 10, 2006·0 cites·28 claims
- 3358US7288671B2Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulatorsUNIV CALIFORNIA·Filed 2006·Granted Oct 30, 2007·0 cites·10 claims
- 3456US7893299B2Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulatorsNEREUS PHARMACEUTICALS INC·Filed 2006·Granted Feb 22, 2011·0 cites·5 claims
- 3553US2012264678A1Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseasesPALLADINO MICHAEL·Filed 2012·Application pending·0 cites
- 3652US2006264495A1Methods of using [3.2.0] heterocyclic compounds and analogs thereofPALLADINO MICHAEL·Filed 2006·Application pending·0 cites
- 3751US2005049294A1Methods of using [3.2.0] heterocyclic compounds and analogs thereofFiled 2004·Application pending·0 cites
- 3850US2006167010A1Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compoundsHAYASHI YOSHIO·Filed 2006·Application pending·0 cites
- 3950US2012238634A1Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulatorsPALLADINO MICHAEL A·Filed 2012·Application pending·0 cites
- 4049US8133915B2Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulatorsPALLADINO MICHAEL A·Filed 2011·Granted Mar 13, 2012·0 cites·2 claims
- 4148US2010168046A1Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseasesNEREUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4248US2012282168A1Methods of sensitizing cancer to therapy-induced cytotoxicityBONAVIDA BENJAMIN·Filed 2012·Application pending·0 cites
- 4347US2009148445A1Methods of sensitizing cancer to therapy-induced cytotoxicityUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
- 4445US2009285836A1Use of salinosporamide a to inhibit metastasisNEREUS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Palladino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →